Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05640661

Effects of Terminal Visual Feedback Therapy After Immersive Virtual Reality in Patients With Chronic Shoulder Pain

Conditions: Shoulder Pain, Movement Disorders

Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 24
Sponsor: University of Malaga

Location: Spain

Summary

The goal of this clinical trial is effect of terminal visual feedback therapy following the use of immersive virtual reality(VRi) effects on pain,kinesiophobia, fear of pain, disability, self-efficacy, grip strength and range of motion in motion in people with chronic shoulder pain compare with just VRi. The main question[s] it aims to answer are:Can terminal visual feedback therapy following the use of immersive virtual reality software decrease movement-evoked pain in patients with chronic shoulder pain compared with just VRi?Can terminal visual feedback therapy following the use of immersive virtual reality software increase shoulder flexion range of motion in patients with chronic shoulder pain compared with just VRi?Participants will use a visual feedback therapy following the use of immersive virtual reality software compared with just specific VRi software

Eligibility Criteria

Inclusion Criteria:People from 18 to 65 years oldShoulder pain of at least three months of evolution located in the proximal anterolateral region of the shoulderPresenting shoulder pain during movements with a history of traumatic or insidious onsetAgree to participate in the study and sign the informed consentExclusion Criteria:Shoulder pain resulting from a dysfunction of the cervical spine.Cognitive deficitsUso of medicines for pain control in the previous 24 hours,A history of neurological or psychiatric disordersAdhesive capsulitis syndrome (limited passive range of motion of the shoulder: external rotation < 30°; elevation < 150°)Patients with shoulder instabilityPrevious surgery of the shoulderRheumatic diseases

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05640661). StuddyBuddy aggregates publicly available trial information.